Literature DB >> 21542868

A central metabolic circuit controlled by QseC in pathogenic Escherichia coli.

Maria Hadjifrangiskou1, Maria Kostakioti, Swaine L Chen, Jeffrey P Henderson, Sarah E Greene, Scott J Hultgren.   

Abstract

The QseC sensor kinase regulates virulence in multiple Gram-negative pathogens, by controlling the activity of the QseB response regulator. We have previously shown that qseC deletion interferes with dephosphorylation of QseB thus unleashing what appears to be an uncontrolled positive feedback loop stimulating increased QseB levels. Deletion of QseC downregulates virulence gene expression and attenuates enterohaemorrhagic and uropathogenic Escherichia coli (EHEC and UPEC), Salmonella typhimurium, and Francisella tularensis. Given that these pathogens employ different infection strategies and virulence factors, we used genome-wide approaches to better understand the role of the QseBC interplay in pathogenesis. We found that deletion of qseC results in misregulation of nucleotide, amino acid, and carbon metabolism. Comparable metabolic changes are seen in EHEC ΔqseC, suggesting that deletion of qseC confers similar pleiotropic effects in these two different pathogens. Disruption of representative metabolic enzymes phenocopied UPEC ΔqseC in vivo and resulted in virulence factor downregulation. We thus propose that in the absence of QseC, the constitutively active QseB leads to pleiotropic effects, impairing bacterial metabolism, and thereby attenuating virulence. These findings provide a basis for the development of antimicrobials targeting the phosphatase activity of QseC, as a means to attenuate a wide range of QseC-bearing pathogens.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21542868      PMCID: PMC3643513          DOI: 10.1111/j.1365-2958.2011.07660.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  57 in total

1.  Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.

Authors:  K Thankavel; B Madison; T Ikeda; R Malaviya; A H Shah; P M Arumugam; S N Abraham
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Intracellular bacterial biofilm-like pods in urinary tract infections.

Authors:  Gregory G Anderson; Joseph J Palermo; Joel D Schilling; Robyn Roth; John Heuser; Scott J Hultgren
Journal:  Science       Date:  2003-07-04       Impact factor: 47.728

3.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.

Authors:  M A Mulvey; Y S Lopez-Boado; C L Wilson; R Roth; W C Parks; J Heuser; S J Hultgren
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

4.  Adhesion to human cells by Escherichia coli lacking the major subunit of a digalactoside-specific pilus-adhesin.

Authors:  B E Uhlin; M Norgren; M Båga; S Normark
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.

Authors:  Chia-Suei Hung; Julie Bouckaert; Danielle Hung; Jerome Pinkner; Charlotte Widberg; Anthony DeFusco; C Gale Auguste; Robert Strouse; Solomon Langermann; Gabriel Waksman; Scott J Hultgren
Journal:  Mol Microbiol       Date:  2002-05       Impact factor: 3.501

6.  Regulation and binding properties of S fimbriae cloned from E. coli strains causing urinary tract infection and meningitis.

Authors:  J Morschhäuser; V Vetter; T Korhonen; B E Uhlin; J Hacker
Journal:  Zentralbl Bakteriol       Date:  1993-04

7.  Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

Authors:  Sheryl S Justice; Chia Hung; Julie A Theriot; Daniel A Fletcher; Gregory G Anderson; Matthew J Footer; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

8.  Effect of different nutritional conditions on the synthesis of tricarboxylic acid cycle enzymes.

Authors:  R S Hanson; D P Cox
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

Review 9.  Structure and function of Escherichia coli met repressor: similarities and contrasts with trp repressor.

Authors:  S E Phillips; P G Stockley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1996-04-29       Impact factor: 6.237

10.  Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli.

Authors:  Kenan C Murphy; Kenneth G Campellone
Journal:  BMC Mol Biol       Date:  2003-12-13       Impact factor: 2.946

View more
  74 in total

1.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Authors:  Sébastien Crépin; Sébastien Houle; Marie-Ève Charbonneau; Michaël Mourez; Josée Harel; Charles M Dozois
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 3.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

4.  What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli.

Authors:  Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

Review 5.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

Review 6.  The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.

Authors:  Bryan B Yoo; Sarkis K Mazmanian
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

7.  QseC Signaling in the Outbreak O104:H4 Escherichia coli Strain Combines Multiple Factors during Infection.

Authors:  Tamara Renata Machado Ribeiro; Bruna Cardinali Lustri; Waldir P Elias; Cristiano Gallina Moreira
Journal:  J Bacteriol       Date:  2019-08-08       Impact factor: 3.490

Review 8.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

9.  Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.

Authors:  Swaine L Chen; Meng Wu; Jeffrey P Henderson; Thomas M Hooton; Michael E Hibbing; Scott J Hultgren; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2013-05-08       Impact factor: 17.956

10.  The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.

Authors:  Kyle A Floyd; Courtney A Mitchell; Allison R Eberly; Spencer J Colling; Ellisa W Zhang; William DePas; Matthew R Chapman; Matthew Conover; Bridget R Rogers; Scott J Hultgren; Maria Hadjifrangiskou
Journal:  J Bacteriol       Date:  2016-09-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.